klow-con and xeloda Cancer drug shortage is forcing doctors to decide which patients get treatment XELODA® (capecitabine) TABLETS
Description
Karginova O., Weekley C.M., Raoul A., Alsayed A., Wu T
Tracking composition prevents the mistake of stopping early because 'the number isn't dropping fast enough.' Another consideration: sermorelin doesn't require the same safety monitoring as exogenous GH
If a patient grows taller and gains weight, we will need to increase the dose
doi: 10.1016/j.clinthera.2020.03.002 131 JinHZhouYYeJQiuCJinWWangL
